Your funds, side by side
These are the lines these funds hold in common, and the companies you own through them. Weights are the ones each document states, with no currency conversion.
- Defiance Autism Impact ETF ETF Series Solutions · 38 lines · as of Jun 30, 2026 · 100.0 %
Add a second fund to see what the two hold in common.
The companies you hold through them
A company's weight in the portfolio is its weight inside each fund, times that fund's share of the portfolio. With no amounts given, the funds weigh the same.
| Holding | Defiance Autism Impact ETF |
|---|---|
| Definium Therapeutics Inc | 4.77 % |
| Neuren Pharmaceuticals Ltd | 3.23 % |
| LIFESTANCE HEALTH GROUP INC | 3.04 % |
| Otsuka Holdings Co Ltd | 2.95 % |
| Acadia Healthcare Co Inc | 2.90 % |
| ACADIA Pharmaceuticals Inc | 2.89 % |
| MAPLIGHT THERAPEUTICS INC | 2.89 % |
| AbbVie Inc | 2.72 % |
| BRIGHTSPRING HEALTH SERVICES INC | 2.70 % |
| Revvity Inc | 2.68 % |
| Bright Horizons Family Solutions Inc | 2.65 % |
| Medicover AB | 2.63 % |
| Ipsen SA | 2.60 % |
| Sumitomo Pharma Co Ltd | 2.60 % |
| Johnson & Johnson | 2.59 % |
| Brainsway Ltd | 2.58 % |
| PEARSON PLC | 2.56 % |
| Anavex Life Sciences Corp | 2.53 % |
| Novartis AG | 2.53 % |
| Life Healthcare Group Holdings Ltd | 2.52 % |
| BioMarin Pharmaceutical Inc | 2.52 % |
| KPJ Healthcare Bhd | 2.51 % |
| Repligen Corp | 2.50 % |
| Roche Holding AG | 2.50 % |
| Supernus Pharmaceuticals Inc | 2.50 % |
| JAZZ PHARMACEUTICALS PLC | 2.50 % |
| Eli Lilly & Co | 2.49 % |
| Bristol-Myers Squibb Co | 2.47 % |
| GSK PLC | 2.46 % |
| Vanda Pharmaceuticals Inc | 2.45 % |
Titelia read 38 lines in these 1 funds.